Approach

A Defined Strategy
for Life Sciences

NewVale provides capital and support for proven, revenue-generating life science services and technologies.

Automated pharmaceutical manufacturing line in a clean production facility

Our Subsectors of Focus

We invest across four core pillars of life sciences outsourcing. Our deep subsector expertise enhances how we source opportunities, underwrite risk, and support companies that have market leadership potential.

Drug Discovery

Lab and research services and enabling technologies that support early stage drug discovery.

Clinical Research

Services and enabling technologies that support clinical research and clinical trial execution.

Manufacturing & Supply Chain

Services and enabling technologies that support pharmaceutical manufacturing, quality, and supply chain operations.

Commercialization

Services and enabling technologies that support launch execution, adoption, and ongoing performance of commercial therapeutics.

Proven, Revenue-Generating Life Science Services and Technologies

01.

Profile

Commercially proven platform with initial revenue traction, multiple customers, and demonstrated product–market fit.

02.

Revenue

$5M to $50M+ at entry

03.

Equity Investment

$10M to $50M equity investments

04.

Margins

Strong margin potential business that can be EBITDA negative or positive at time of investment

05.

Flexibility

Flexibility to be a large minority or majority investment

06.

Business models

Outsourced services, technologies, and software

How We Create Value

Abstract rows symbolizing structured processes and organization

Flexible Capital

Right-sized checks to accelerate thoughtful growth

Abstract layered structure representing scalable systems

Scale Execution

Build the commercial system and industrialize the operating model to support scale

Abstract network connections representing data and technology infrastructure

Ecosystem Hub

Valuable customer connectivity, senior advisor access, and future acquiror visibility

NextTeam